The biotech and life sciences industries, which often struggle to find appropriate talent for their open positions, now face questions about how the Supreme Court's Dobbs v. Jackson Women's Health Organization decision revoking the federal right to an abortion will impact talent pools. “The life science industry itself really makes a lot of site selection decisions on workforce,” said Patricia Larrabee, founder and president of Facility Logix, a Maryland-based consulting firm that helps clients navigate the life sciences real estate industry. “And if literally half of the workforce is disinclined to be in a state where they have limited rights, it will have an impact.” Larrabee believes that the states and cities on the wrong side of the expanding wave of abortion restrictions will pay a price when it comes to growing their biotech and life sciences markets, eventually dampening development demand for new labs. 
Any workforce impact of changing laws and restrictions will likely be felt especially hard in up-and-coming markets in red states. A recent report by CBRE underscored just how difficult it is to find scientific talent: Despite growth in graduates and funding, the sector had 0.6% unemployment in April 2022.A significant number…  Read the full story here. | 
